Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail

Jeffrey R. Kugelman, Johanny Kugelman-Tonos, Jason T. Ladner, James Pettit, Carolyn M. Keeton, Elyse R. Nagle, Karla Y. Garcia, Jeffrey W. Froude, Ana I. Kuehne, Jens H. Kuhn, Sina Bavari, Larry Zeitlin, John M. Dye, Gene G. Olinger, Mariano Sanchez-Lockhart, Gustavo F. Palacios

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

MB-003, a plant-derived monoclonal antibody cocktail used effectively in treatment of Ebola virus infection in non-human primates, was unable to protect two of six animals when initiated 1 or 2 days post-infection. We characterized a mechanism of viral escape in one of the animals, after observation of two clusters of genomic mutations that resulted in five nonsynonymous mutations in the monoclonal antibody target sites. These mutations were linked to a reduction in antibody binding and later confirmed to be present in a viral isolate that was not neutralized in vitro. Retrospective evaluation of a second independent study allowed the identification of a similar case. Four SNPs in previously identified positions were found in this second fatality, suggesting that genetic drift could be a potential cause for treatment failure. These findings highlight the importance selecting different target domains for each component of the cocktail to minimize the potential for viral escape.

Original languageEnglish (US)
Pages (from-to)2111-2120
Number of pages10
JournalCell Reports
Volume12
Issue number12
DOIs
StatePublished - Sep 29 2015

Fingerprint

Ebolavirus
Viruses
Primates
Animals
Monoclonal Antibodies
Mutation
Plantibodies
Antibodies
Ebola Hemorrhagic Fever
Genetic Drift
Treatment Failure
Single Nucleotide Polymorphism
Observation
Infection
2,6-diisopropyl-4-(1-hydroxy-2,2,2-trifluoroethyl)phenol

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Kugelman, J. R., Kugelman-Tonos, J., Ladner, J. T., Pettit, J., Keeton, C. M., Nagle, E. R., ... Palacios, G. F. (2015). Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail. Cell Reports, 12(12), 2111-2120. https://doi.org/10.1016/j.celrep.2015.08.038

Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail. / Kugelman, Jeffrey R.; Kugelman-Tonos, Johanny; Ladner, Jason T.; Pettit, James; Keeton, Carolyn M.; Nagle, Elyse R.; Garcia, Karla Y.; Froude, Jeffrey W.; Kuehne, Ana I.; Kuhn, Jens H.; Bavari, Sina; Zeitlin, Larry; Dye, John M.; Olinger, Gene G.; Sanchez-Lockhart, Mariano; Palacios, Gustavo F.

In: Cell Reports, Vol. 12, No. 12, 29.09.2015, p. 2111-2120.

Research output: Contribution to journalArticle

Kugelman, JR, Kugelman-Tonos, J, Ladner, JT, Pettit, J, Keeton, CM, Nagle, ER, Garcia, KY, Froude, JW, Kuehne, AI, Kuhn, JH, Bavari, S, Zeitlin, L, Dye, JM, Olinger, GG, Sanchez-Lockhart, M & Palacios, GF 2015, 'Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail', Cell Reports, vol. 12, no. 12, pp. 2111-2120. https://doi.org/10.1016/j.celrep.2015.08.038
Kugelman JR, Kugelman-Tonos J, Ladner JT, Pettit J, Keeton CM, Nagle ER et al. Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail. Cell Reports. 2015 Sep 29;12(12):2111-2120. https://doi.org/10.1016/j.celrep.2015.08.038
Kugelman, Jeffrey R. ; Kugelman-Tonos, Johanny ; Ladner, Jason T. ; Pettit, James ; Keeton, Carolyn M. ; Nagle, Elyse R. ; Garcia, Karla Y. ; Froude, Jeffrey W. ; Kuehne, Ana I. ; Kuhn, Jens H. ; Bavari, Sina ; Zeitlin, Larry ; Dye, John M. ; Olinger, Gene G. ; Sanchez-Lockhart, Mariano ; Palacios, Gustavo F. / Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail. In: Cell Reports. 2015 ; Vol. 12, No. 12. pp. 2111-2120.
@article{e423aec83a3641318a773a5faea9fc31,
title = "Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail",
abstract = "MB-003, a plant-derived monoclonal antibody cocktail used effectively in treatment of Ebola virus infection in non-human primates, was unable to protect two of six animals when initiated 1 or 2 days post-infection. We characterized a mechanism of viral escape in one of the animals, after observation of two clusters of genomic mutations that resulted in five nonsynonymous mutations in the monoclonal antibody target sites. These mutations were linked to a reduction in antibody binding and later confirmed to be present in a viral isolate that was not neutralized in vitro. Retrospective evaluation of a second independent study allowed the identification of a similar case. Four SNPs in previously identified positions were found in this second fatality, suggesting that genetic drift could be a potential cause for treatment failure. These findings highlight the importance selecting different target domains for each component of the cocktail to minimize the potential for viral escape.",
author = "Kugelman, {Jeffrey R.} and Johanny Kugelman-Tonos and Ladner, {Jason T.} and James Pettit and Keeton, {Carolyn M.} and Nagle, {Elyse R.} and Garcia, {Karla Y.} and Froude, {Jeffrey W.} and Kuehne, {Ana I.} and Kuhn, {Jens H.} and Sina Bavari and Larry Zeitlin and Dye, {John M.} and Olinger, {Gene G.} and Mariano Sanchez-Lockhart and Palacios, {Gustavo F.}",
year = "2015",
month = "9",
day = "29",
doi = "10.1016/j.celrep.2015.08.038",
language = "English (US)",
volume = "12",
pages = "2111--2120",
journal = "Cell Reports",
issn = "2211-1247",
publisher = "Cell Press",
number = "12",

}

TY - JOUR

T1 - Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail

AU - Kugelman, Jeffrey R.

AU - Kugelman-Tonos, Johanny

AU - Ladner, Jason T.

AU - Pettit, James

AU - Keeton, Carolyn M.

AU - Nagle, Elyse R.

AU - Garcia, Karla Y.

AU - Froude, Jeffrey W.

AU - Kuehne, Ana I.

AU - Kuhn, Jens H.

AU - Bavari, Sina

AU - Zeitlin, Larry

AU - Dye, John M.

AU - Olinger, Gene G.

AU - Sanchez-Lockhart, Mariano

AU - Palacios, Gustavo F.

PY - 2015/9/29

Y1 - 2015/9/29

N2 - MB-003, a plant-derived monoclonal antibody cocktail used effectively in treatment of Ebola virus infection in non-human primates, was unable to protect two of six animals when initiated 1 or 2 days post-infection. We characterized a mechanism of viral escape in one of the animals, after observation of two clusters of genomic mutations that resulted in five nonsynonymous mutations in the monoclonal antibody target sites. These mutations were linked to a reduction in antibody binding and later confirmed to be present in a viral isolate that was not neutralized in vitro. Retrospective evaluation of a second independent study allowed the identification of a similar case. Four SNPs in previously identified positions were found in this second fatality, suggesting that genetic drift could be a potential cause for treatment failure. These findings highlight the importance selecting different target domains for each component of the cocktail to minimize the potential for viral escape.

AB - MB-003, a plant-derived monoclonal antibody cocktail used effectively in treatment of Ebola virus infection in non-human primates, was unable to protect two of six animals when initiated 1 or 2 days post-infection. We characterized a mechanism of viral escape in one of the animals, after observation of two clusters of genomic mutations that resulted in five nonsynonymous mutations in the monoclonal antibody target sites. These mutations were linked to a reduction in antibody binding and later confirmed to be present in a viral isolate that was not neutralized in vitro. Retrospective evaluation of a second independent study allowed the identification of a similar case. Four SNPs in previously identified positions were found in this second fatality, suggesting that genetic drift could be a potential cause for treatment failure. These findings highlight the importance selecting different target domains for each component of the cocktail to minimize the potential for viral escape.

UR - http://www.scopus.com/inward/record.url?scp=84942826507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942826507&partnerID=8YFLogxK

U2 - 10.1016/j.celrep.2015.08.038

DO - 10.1016/j.celrep.2015.08.038

M3 - Article

VL - 12

SP - 2111

EP - 2120

JO - Cell Reports

JF - Cell Reports

SN - 2211-1247

IS - 12

ER -